Literature DB >> 19585622

MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia.

Justin L Mott1.   

Abstract

MicroRNAs are a class of small regulatory RNAs that function to modulate protein expression. This control allows for fine-tuning of the cellular phenotype, including regulation of proliferation, cell signaling, and apoptosis; not surprisingly, microRNAs contribute to liver cancer biology. Recent investigations in human liver cancers and tumor-derived cell lines have demonstrated decreased or increased expression of particular microRNAs in hepatobiliary cancer cells. Based on predicted and validated protein targets as well as functional consequences of altered expression, microRNAs with decreased expression in liver tumor cells may normally aid in limiting neoplastic transformation. Conversely, selected microRNAs that are up-regulated in liver tumor cells can promote malignant features, contributing to carcinogenesis. In addition, microRNAs themselves are subject to regulated expression, including regulation by tumor suppressor and oncogene pathways. This review will focus on the expression and function of cancer-related microRNAs, including their intimate involvement in tumor suppressor and oncogene signaling networks relevant to hepatobiliary neoplasia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585622      PMCID: PMC2721015          DOI: 10.1002/hep.23010

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  64 in total

1.  Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.

Authors:  Sergei B Koralov; Stefan A Muljo; Gunther R Galler; Azra Krek; Tirtha Chakraborty; Chryssa Kanellopoulou; Kari Jensen; Bradley S Cobb; Matthias Merkenschlager; Nikolaus Rajewsky; Klaus Rajewsky
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

Review 2.  MicroRNAs and cancer epigenetics.

Authors:  Muller Fabbri
Journal:  Curr Opin Investig Drugs       Date:  2008-06

3.  Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

Authors:  H Azechi; N Nishida; Y Fukuda; T Nishimura; M Minata; H Katsuma; M Kuno; T Ito; T Komeda; R Kita; R Takahashi; K Nakao
Journal:  Oncology       Date:  2001       Impact factor: 2.935

4.  MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.

Authors:  Irena Ivanovska; Alexey S Ball; Robert L Diaz; Jill F Magnus; Miho Kibukawa; Janell M Schelter; Sumire V Kobayashi; Lee Lim; Julja Burchard; Aimee L Jackson; Peter S Linsley; Michele A Cleary
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

5.  Identification of metastasis-related microRNAs in hepatocellular carcinoma.

Authors:  Anuradha Budhu; Hu-Liang Jia; Marshonna Forgues; Chang-Gong Liu; David Goldstein; Amy Lam; Krista A Zanetti; Qing-Hai Ye; Lun-Xiu Qin; Carlo M Croce; Zhao-You Tang; Xin Wei Wang
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

6.  The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

Authors:  Manav Korpal; Esther S Lee; Guohong Hu; Yibin Kang
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

7.  A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.

Authors:  Kristina A Cole; Edward F Attiyeh; Yael P Mosse; Michael J Laquaglia; Sharon J Diskin; Garrett M Brodeur; John M Maris
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

8.  Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet.

Authors:  Volodymyr P Tryndyak; Sharon A Ross; Frederick A Beland; Igor P Pogribny
Journal:  Mol Carcinog       Date:  2009-06       Impact factor: 4.784

9.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

Authors:  Changchun Xiao; Lakshmi Srinivasan; Dinis Pedro Calado; Heide Christine Patterson; Baochun Zhang; Jing Wang; Joel M Henderson; Jeffrey L Kutok; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

10.  Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.

Authors:  Andrea Ventura; Amanda G Young; Monte M Winslow; Laura Lintault; Alex Meissner; Stefan J Erkeland; Jamie Newman; Roderick T Bronson; Denise Crowley; James R Stone; Rudolf Jaenisch; Phillip A Sharp; Tyler Jacks
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

View more
  44 in total

Review 1.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

2.  MicroRNA-2053 overexpression inhibits the development and progression of hepatocellular carcinoma.

Authors:  Tao Song; Ke Ma; Cui Zhao; Jijin Yang; Jingyu Liu
Journal:  Oncol Lett       Date:  2019-06-20       Impact factor: 2.967

3.  Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker.

Authors:  Jing Shen; Antai Wang; Qiao Wang; Irina Gurvich; Abby B Siegel; Helen Remotti; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-14       Impact factor: 4.254

4.  Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis.

Authors:  Athena Starlard-Davenport; Volodymyr Tryndyak; Oksana Kosyk; Sharon R Ross; Ivan Rusyn; Frederick A Beland; Igor P Pogribny
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-06

5.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

6.  Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis.

Authors:  Athena Starlard-Davenport; Volodymyr Tryndyak; Oksana Kosyk; Sharon R Ross; Ivan Rusyn; Frederick A Beland; Igor P Pogribny
Journal:  World Rev Nutr Diet       Date:  2010-04-30       Impact factor: 0.575

7.  A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.

Authors:  Heping Yang; Tony W H Li; Jian Peng; Xiaoli Tang; Kwang Suk Ko; Meng Xia; Maria-Angeles Aller
Journal:  Gastroenterology       Date:  2011-03-24       Impact factor: 22.682

8.  Dysregulation of microRNA biosynthesis enzyme Dicer plays an important role in gastric cancer progression.

Authors:  Jin Zhang; Xin-Hua Zhang; Cai-Xia Wang; Biao Liu; Xiang-Shan Fan; Juan-Juan Wen; Qun-Li Shi; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.

Authors:  Heping Yang; Michele E Cho; Tony W H Li; Hui Peng; Kwang Suk Ko; Jose M Mato; Shelly C Lu
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

10.  MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network.

Authors:  Jianjun Zhang; Haiyan Guo; Guanxiang Qian; Shengfang Ge; Huifeng Ji; Xiaobo Hu; Wantao Chen
Journal:  Mol Cancer       Date:  2010-08-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.